Attached files

file filename
EX-32.2 - EXHIBIT 32.2 CFO 906 CERT FY2017 - BOSTON SCIENTIFIC CORPexhibit322-cfo906201710xk.htm
EX-32.1 - EXHIBIT 32.1 CEO 906 CERT FY2017 - BOSTON SCIENTIFIC CORPexhibit321-ceo906201710xk.htm
EX-31.2 - EXHIBIT 31.2 CFO 302 CERT FY2017 - BOSTON SCIENTIFIC CORPexhibit312-cfo302201710xk.htm
EX-31.1 - EXHIBIT 31.1 CEO 302 CERT FY2017 - BOSTON SCIENTIFIC CORPexhibit311-ceo302201710xk.htm
EX-23 - EXHIBIT 23 - E&Y CONSENT FY2017 - BOSTON SCIENTIFIC CORPexhibit23-2017eyconsent.htm
EX-21 - EXHIBIT 21 - FY2017 LIST OF SUBSIDIARIES DATED FEB 12, 2016 - BOSTON SCIENTIFIC CORPexhibit21-listofsubsidiari.htm
10-K - 10-K FY2017 - BOSTON SCIENTIFIC CORPa2017form10-k.htm

EXHIBIT 12


BOSTON SCIENTIFIC CORPORATION
STATEMENT OF COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES (unaudited)

 
Year Ended December 31,
(in millions)
2017
2016
2015
2014
2013
Fixed charges
 
 
 
 
 
Interest expense and amortization of debt issuance costs (a)
$
229

$
233

$
284

$
216

$
324

Interest portion of rental expense
30

27

25

25

25

Total fixed charges
$
259

$
260

$
309

$
241

$
349

 
 
 
 
 
 
Earnings
 
 
 
 
 
Income (loss) before income taxes
$
933

$
177

$
(650
)
$
(509
)
$
(223
)
Fixed charges, per above
259

260

309

241

349

Total earnings (deficit), adjusted
$
1,192

$
437

$
(341
)
$
(268
)
$
126

 
 
 
 
 

Ratio of earnings to fixed charges (b)
4.60

1.68





0.36

 
 
 

 


a) The interest expense included in fixed charges above reflects only interest on third party indebtedness and excludes any interest expense accrued on uncertain tax positions, as permitted by Financial Accounting Standards Board Accounting Standards Codification™ Topic 740, Income Taxes.

b) Earnings were deficient by $341 million in 2015 and $268 million in 2014.

The ratio of earnings to fixed charges for the year ended December 31, 2017, is not necessarily indicative of results that may be expected in future years. The data above include certain charges and/or credits recorded in conjunction with amortization, goodwill and intangible asset impairments, acquisition and divestiture-related activities, restructuring and restructuring-related activities, pension termination charges, litigation-related charges, debt extinguishment charges, certain investment impairments and/or certain tax items. The data above should be read in conjunction with our consolidated financial statements, including the notes thereto, included in Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K.